Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding. (Q39143880)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

Massimiliano Castellazzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Dario Di Luca

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Alessandro Trentini

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Daria Bortolotti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

Maria Cristina Manfrinato

2 March 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Tiziana Bellini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1

Roberta Rizzo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

10

Enrico Fainardi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

5

Antonella Rotola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

7

Loredana Melchiorri

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Franco Dallocchio

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

5 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

Molecular and Cellular Biochemistry

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

243-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s11010-013-1708-5

2 March 2020

exact match

0 references

cites work

HLA-G and inflammatory diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G and immune tolerance in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Implication of HLA-G molecule in heart-graft acceptance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G in cancer: a way to turn off the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Elevation of plasma soluble human leukocyte antigen-G in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Emerging topics and new perspectives on HLA-G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G 14-bp polymorphism regulates the methotrexate response in rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Human leukocyte antigen-G is closely associated with tumor immune escape in gastric cancer by increasing local regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6--STAT3 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Presenilin/gamma-secretase and alpha-secretase-like peptidases cleave human MHC Class I proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Matrix metalloproteinases and the regulation of tissue remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Matrix metalloproteinases in health and disease: insights from dermatopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

The matrix metalloproteinase-7 regulates the extracellular shedding of syndecan-2 from colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Matrix metalloproteinases as modulators of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Gelatinase B: a tuner and amplifier of immune functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Membrane-bound HLA-G activates proliferation and interferon-gamma production by uterine natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Western blot of proteins from Coomassie-stained polyacrylamide gels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

A unique substrate recognition profile for matrix metalloproteinase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

SitePredicting the cleavage of proteinase substrates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Detection of HLA-G5 secreting cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Substrate hydrolysis by matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Nitric oxide produces HLA-G nitration and induces metalloprotease-dependent shedding creating a tolerogenic milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-013-1708-5

HLA-G has a concentration-dependent effect on the generation of an allo-CTL response

21 January 2018

1 reference

12 December 2020

Soluble beta 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease

1 reference

12 December 2020

Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8

1 reference

12 December 2020

HLA-G may predict the disease course in patients with early rheumatoid arthritis

1 reference

12 December 2020

Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression

1 reference

12 December 2020

Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis

1 reference

12 December 2020

Soluble nonclassical HLA generated by the metalloproteinase pathway

1 reference

12 December 2020

Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients

1 reference

12 December 2020

Human leukocyte antigen-G (HLA-G) expression in biliary epithelial cells is associated with allograft acceptance in liver-kidney transplantation

1 reference

12 December 2020

Human leukocyte antigen-G molecules are constitutively expressed by synovial fibroblasts and upmodulated in osteoarthritis

1 reference

12 December 2020

Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules

1 reference

12 December 2020

Matrix metalloproteinases: structures, evolution, and diversification

1 reference

12 December 2020

Decreased production of human leukocyte antigen G molecules in sinonasal polyposis

1 reference

12 December 2020

[HLA-G: immunoregulatory molecule involved in allograft acceptance]

1 reference

12 December 2020

Expression of the non-classical HLA-G antigen in tumor cell lines is extremely restricted.

1 reference

12 December 2020

Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms

1 reference

12 December 2020

10.1007/S11010-013-1708-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json

release_2gkgarixufe7bealhlabdcv4ka

2 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2gkgarixufe7bealhlabdcv4ka

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23737137%20AND%20SRC:MED&resulttype=core&format=json